866-997-4948(US-Canada Toll Free)

United States Herceptin Biosimilar Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

In this report, the United States Herceptin Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Herceptin Biosimilar in these regions, from 2012 to 2022 (forecast).

United States Herceptin Biosimilar market competition by top manufacturers/players, with Herceptin Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Mylan
Amgen
Mabion
AryoGen Biopharma
Genor Biopharma
The Instituto Vital Brazil
Celltrion
Gedeon Richter

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Capsule
Tablet
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Herceptin Biosimilar for each application, including
Healthcare&Pharmaceuticals
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Herceptin Biosimilar Market Report 2017
1 Herceptin Biosimilar Overview
1.1 Product Overview and Scope of Herceptin Biosimilar
1.2 Classification of Herceptin Biosimilar by Product Category
1.2.1 United States Herceptin Biosimilar Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Herceptin Biosimilar Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Others
1.3 United States Herceptin Biosimilar Market by Application/End Users
1.3.1 United States Herceptin Biosimilar Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Healthcare&Pharmaceuticals
1.3.3 Others
1.4 United States Herceptin Biosimilar Market by Region
1.4.1 United States Herceptin Biosimilar Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Herceptin Biosimilar Status and Prospect (2012-2022)
1.4.3 Southwest Herceptin Biosimilar Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Herceptin Biosimilar Status and Prospect (2012-2022)
1.4.5 New England Herceptin Biosimilar Status and Prospect (2012-2022)
1.4.6 The South Herceptin Biosimilar Status and Prospect (2012-2022)
1.4.7 The Midwest Herceptin Biosimilar Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Herceptin Biosimilar (2012-2022)
1.5.1 United States Herceptin Biosimilar Sales and Growth Rate (2012-2022)
1.5.2 United States Herceptin Biosimilar Revenue and Growth Rate (2012-2022)

2 United States Herceptin Biosimilar Market Competition by Players/Suppliers
2.1 United States Herceptin Biosimilar Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Herceptin Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Herceptin Biosimilar Average Price by Players/Suppliers (2012-2017)
2.4 United States Herceptin Biosimilar Market Competitive Situation and Trends
2.4.1 United States Herceptin Biosimilar Market Concentration Rate
2.4.2 United States Herceptin Biosimilar Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Type

3 United States Herceptin Biosimilar Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Herceptin Biosimilar Sales and Market Share by Region (2012-2017)
3.2 United States Herceptin Biosimilar Revenue and Market Share by Region (2012-2017)
3.3 United States Herceptin Biosimilar Price by Region (2012-2017)

4 United States Herceptin Biosimilar Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Herceptin Biosimilar Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Herceptin Biosimilar Revenue and Market Share by Type (2012-2017)
4.3 United States Herceptin Biosimilar Price by Type (2012-2017)
4.4 United States Herceptin Biosimilar Sales Growth Rate by Type (2012-2017)

5 United States Herceptin Biosimilar Sales (Volume) by Application (2012-2017)
5.1 United States Herceptin Biosimilar Sales and Market Share by Application (2012-2017)
5.2 United States Herceptin Biosimilar Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Herceptin Biosimilar Players/Suppliers Profiles and Sales Data
6.1 Mylan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Herceptin Biosimilar Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Mylan Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Herceptin Biosimilar Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Mabion
6.3.2 Herceptin Biosimilar Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mabion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AryoGen Biopharma
6.4.2 Herceptin Biosimilar Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Genor Biopharma
6.5.2 Herceptin Biosimilar Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 The Instituto Vital Brazil
6.6.2 Herceptin Biosimilar Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Celltrion
6.7.2 Herceptin Biosimilar Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Celltrion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Gedeon Richter
6.8.2 Herceptin Biosimilar Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Herceptin Biosimilar Manufacturing Cost Analysis
7.1 Herceptin Biosimilar Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Herceptin Biosimilar

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Herceptin Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Herceptin Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Herceptin Biosimilar Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Herceptin Biosimilar Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Herceptin Biosimilar Sales Volume Forecast by Type (2017-2022)
11.3 United States Herceptin Biosimilar Sales Volume Forecast by Application (2017-2022)
11.4 United States Herceptin Biosimilar Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Herceptin Biosimilar
Figure United States Herceptin Biosimilar Market Size (K MT) by Type (2012-2022)
Figure United States Herceptin Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure United States Herceptin Biosimilar Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Herceptin Biosimilar by Application in 2016
Figure Healthcare&Pharmaceuticals Examples
Table Key Downstream Customer in Healthcare&Pharmaceuticals
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Herceptin Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure The West Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Herceptin Biosimilar Sales (K MT) and Growth Rate (2012-2022)
Figure United States Herceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Herceptin Biosimilar Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Herceptin Biosimilar Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Herceptin Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Herceptin Biosimilar Sales Share by Players/Suppliers
Figure 2017 United States Herceptin Biosimilar Sales Share by Players/Suppliers
Figure United States Herceptin Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Herceptin Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Herceptin Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Herceptin Biosimilar Revenue Share by Players/Suppliers
Figure 2017 United States Herceptin Biosimilar Revenue Share by Players/Suppliers
Table United States Market Herceptin Biosimilar Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Herceptin Biosimilar Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Herceptin Biosimilar Market Share of Top 3 Players/Suppliers
Figure United States Herceptin Biosimilar Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Herceptin Biosimilar Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Herceptin Biosimilar Product Category
Table United States Herceptin Biosimilar Sales (K MT) by Region (2012-2017)
Table United States Herceptin Biosimilar Sales Share by Region (2012-2017)
Figure United States Herceptin Biosimilar Sales Share by Region (2012-2017)
Figure United States Herceptin Biosimilar Sales Market Share by Region in 2016
Table United States Herceptin Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Herceptin Biosimilar Revenue Share by Region (2012-2017)
Figure United States Herceptin Biosimilar Revenue Market Share by Region (2012-2017)
Figure United States Herceptin Biosimilar Revenue Market Share by Region in 2016
Table United States Herceptin Biosimilar Price (USD/MT) by Region (2012-2017)
Table United States Herceptin Biosimilar Sales (K MT) by Type (2012-2017)
Table United States Herceptin Biosimilar Sales Share by Type (2012-2017)
Figure United States Herceptin Biosimilar Sales Share by Type (2012-2017)
Figure United States Herceptin Biosimilar Sales Market Share by Type in 2016
Table United States Herceptin Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Herceptin Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Herceptin Biosimilar by Type (2012-2017)
Figure Revenue Market Share of Herceptin Biosimilar by Type in 2016
Table United States Herceptin Biosimilar Price (USD/MT) by Types (2012-2017)
Figure United States Herceptin Biosimilar Sales Growth Rate by Type (2012-2017)
Table United States Herceptin Biosimilar Sales (K MT) by Application (2012-2017)
Table United States Herceptin Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Herceptin Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Herceptin Biosimilar Sales Market Share by Application in 2016
Table United States Herceptin Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Herceptin Biosimilar Sales Growth Rate by Application (2012-2017)
Table Mylan Basic Information List
Table Mylan Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Mylan Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Mylan Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Amgen Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Amgen Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Mabion Basic Information List
Table Mabion Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mabion Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Mabion Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Mabion Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AryoGen Biopharma Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure AryoGen Biopharma Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure AryoGen Biopharma Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Genor Biopharma Basic Information List
Table Genor Biopharma Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Genor Biopharma Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Genor Biopharma Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Genor Biopharma Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table The Instituto Vital Brazil Basic Information List
Table The Instituto Vital Brazil Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure The Instituto Vital Brazil Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure The Instituto Vital Brazil Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure The Instituto Vital Brazil Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Celltrion Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Celltrion Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Gedeon Richter Basic Information List
Table Gedeon Richter Herceptin Biosimilar Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gedeon Richter Herceptin Biosimilar Sales Growth Rate (2012-2017)
Figure Gedeon Richter Herceptin Biosimilar Sales Market Share in United States (2012-2017)
Figure Gedeon Richter Herceptin Biosimilar Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Herceptin Biosimilar
Figure Manufacturing Process Analysis of Herceptin Biosimilar
Figure Herceptin Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Herceptin Biosimilar Major Players/Suppliers in 2016
Table Major Buyers of Herceptin Biosimilar
Table Distributors/Traders List
Figure United States Herceptin Biosimilar Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Herceptin Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Herceptin Biosimilar Price (USD/MT) Trend Forecast (2017-2022)
Table United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Type in 2022
Table United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Application in 2022
Table United States Herceptin Biosimilar Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Herceptin Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume Share Forecast by Region (2017-2022)
Figure United States Herceptin Biosimilar Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *